Clinical trial
Effects of Oral Intake of BK329 on Body Fat Reduction in Adults With Overweight or Obesity: a Randomized, Double-blind, Placebo-controlled Clinical Trial
NCT06628791 is registered in ClinicalTrials.gov with Pusan National University Yangsan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Oral Intake of BK329 on Body Fat Reduction in Adults With Overweight or Obesity: a Randomized, Double-blind, Placebo-controlled Clinical Trial
- Lead sponsor
- Pusan National University Yangsan Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 26, 2024
- Completion date
- December 31, 2024
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
obesity and overweight